Biology · Biotechnology
Work through this past-paper style MCQ, then read the full explanation. Practice more biology questions on mMCQ with adaptive drills and topic analytics.
In biotechnology, vaccines can be developed by cloning of:
- A
Gene for antigen of pathogen
- B
Gene for receptor of the patient
- C
Gene for antigen of patient
- D
Gene for antibody of patient
The correct answer is Option A: Gene for antigen of pathogen. In vaccine development, the goal is to stimulate an immune response against a specific pathogen. This is achieved by cloning the gene that produces the antigen, which is a substance that induces an immune response. The other options are incorrect because:
- Option B refers to the gene for the receptor of the patient, which is not involved in vaccine creation.
- Option C suggests using the gene for the patient's antigen, which is not relevant as vaccines aim to target pathogens, not the individual.
- Option D involves the gene for antibodies of the patient, which again does not contribute to the creation of a vaccine.
Thus, the focus should be on the pathogen's antigen gene for effective vaccine development.
This option is correct because vaccines are often developed by cloning the gene that encodes the antigen of a pathogen, which triggers an immune response in the host.
This option is incorrect because receptors of the patient do not play a direct role in the development of vaccines; rather, they are involved in the immune response once the vaccine is administered.
This option is incorrect because the gene for the antigen of the patient is not relevant to vaccine development, which focuses on the pathogens, not the individual receiving the vaccine.
This option is incorrect because antibodies are produced by the immune system in response to an antigen. Cloning the gene for antibodies does not directly contribute to vaccine development.
Tagged under Biology · Biotechnology · 2025